Skip to content
  • Sunday, 26 July 2026
  • 4:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu May 1, 2026 0

The World Health Organization (WHO) has unveiled groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, aiming for faster, more…

Read More
Data Science & Bioinformatics

The Rise of Local AI-Powered Audio Transcription: Enhancing Privacy and Efficiency with Whisper and Faster-Whisper

Evan Lee Salim Apr 29, 2026 0

In a significant advancement for data privacy and operational efficiency, the development of robust, local audio transcription systems leveraging technologies…

Read More
Data Science & Bioinformatics

5 Docker Best Practices for Faster Builds and Smaller Images

Evan Lee Salim Apr 25, 2026 0

The rapid evolution of modern software development has seen containerization emerge as a cornerstone technology, with Docker leading the charge…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu Apr 24, 2026 0

The World Health Organization (WHO) has unveiled a suite of groundbreaking recommendations aimed at revolutionizing tuberculosis (TB) diagnostics, emphasizing speed,…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu Apr 17, 2026 0

The global landscape of tuberculosis (TB) diagnostics is undergoing a significant transformation following new recommendations issued by the World Health…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States

Reynand Amr Wu Apr 9, 2026 0

The global fight against tuberculosis (TB) has reached a pivotal juncture, with the World Health Organization (WHO) unveiling transformative new…

Read More
Clinical Diagnostics & Pathology

Breath-based VOC Analysis Offers Faster, Non-invasive Assessment of Gut Microbiome Health and Earlier Disease Detection

Reynand Amr Wu Apr 6, 2026 0

A groundbreaking study conducted by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…

Read More
Laboratory Automation & Robotics

Terray’s TerraBind Delivers 26x Faster Inference and Enhanced Accuracy, Challenging Diffusion-Based AI Models in Drug Discovery

Lana Keisha Apr 6, 2026 0

In a significant development poised to reshape the landscape of AI-driven drug discovery, Terray Therapeutics, a Los Angeles-based startup, has…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu Apr 1, 2026 0

The World Health Organization (WHO) has unveiled a set of groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, emphasizing…

Read More
Clinical Diagnostics & Pathology

Breath-based VOC analysis could give clinical labs a faster, noninvasive way to assess gut microbiome health and detect disease earlier.

Reynand Amr Wu Mar 30, 2026 0

The landscape of clinical diagnostics is on the cusp of a significant transformation, with new research pointing towards a rapid,…

Read More

Posts pagination

1 2 3
TWiV 1293: The enemy of your parasite is your friendTWiV 1287: Ancient herpesviruses and modern dementiaFake testimonials, no pharmacy and an FDA warning: how Medvi built a $1.8 billion telehealth company in the gaps between regulatorsSolving the Two-Century Geological Mystery of the Dolomite Problem through Atomic Simulation and Pulsed Growth
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ